Search
Cigna Group
CI270.020USD
+2.700+1.01%
Close 04/02, 16:00（ET）Quotes delayed by 15 min
77.81BMarket Cap
12.09P/E TTM
More Details of Cigna Group Company
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Cigna Group Info
Ticker SymbolCI
Company nameCigna Group
IPO dateApr 01, 1982
CEOCordani (David M)
Number of employees73500
Security typeOrdinary Share
Fiscal year-endApr 01
Address900 Cottage Grove Road
CityBLOOMFIELD
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code06002
Phone18602266000
Websitehttps://www.thecignagroup.com/
Ticker SymbolCI
IPO dateApr 01, 1982
CEOCordani (David M)
Company Executives of Cigna Group
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
671.41K
+3.83%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
70.87K
+16.15%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
--
Ms. Ann M. Dennison
Ms. Ann M. Dennison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.75K
+62.30%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+10.44%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
--
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
--
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
--
Ms. Neesha Hathi
Ms. Neesha Hathi
Independent Director
Independent Director
3.37K
--
Mr. Eric J. Foss
Mr. Eric J. Foss
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
671.41K
+3.83%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
70.87K
+16.15%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
--
Ms. Ann M. Dennison
Ms. Ann M. Dennison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.75K
+62.30%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+10.44%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
--
Revenue Breakdown
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
By BusinessUSD
Name
Revenue
Proportion
Pharmacy revenues
216.67B
0.00%
Network revenues
125.57B
0.00%
Home delivery and specialty revenues
80.49B
0.00%
Fees and other revenues
16.92B
0.00%
Other revenues
13.33B
0.00%
Intercompany eliminations
-2.78B
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharmacy revenues
216.67B
0.00%
Network revenues
125.57B
0.00%
Home delivery and specialty revenues
80.49B
0.00%
Fees and other revenues
16.92B
0.00%
Other revenues
13.33B
0.00%
Intercompany eliminations
-2.78B
0.00%
Shareholding Stats
Updated: Sat, Feb 21
Updated: Sat, Feb 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.03%
BlackRock Institutional Trust Company, N.A.
5.10%
State Street Investment Management (US)
4.68%
MFS Investment Management
4.33%
Dodge & Cox
4.22%
Other
71.63%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.03%
BlackRock Institutional Trust Company, N.A.
5.10%
State Street Investment Management (US)
4.68%
MFS Investment Management
4.33%
Dodge & Cox
4.22%
Other
71.63%
Shareholder Types
Shareholders
Proportion
Investment Advisor
50.68%
Investment Advisor/Hedge Fund
30.99%
Pension Fund
2.56%
Research Firm
2.55%
Bank and Trust
1.62%
Sovereign Wealth Fund
1.53%
Hedge Fund
1.41%
Corporation
1.05%
Individual Investor
0.37%
Other
7.22%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
2963
241.25M
91.50%
-5.38M
2025Q4
2907
242.25M
91.45%
+168.59K
2025Q3
2972
242.12M
91.90%
+1.54M
2025Q2
2981
240.55M
93.84%
-5.16M
2025Q1
2971
246.39M
94.63%
-8.92M
2024Q4
2988
249.03M
93.14%
+458.77K
2024Q3
2914
248.98M
92.53%
-1.29M
2024Q2
2894
250.44M
95.06%
-5.89M
2024Q1
2849
256.08M
92.56%
-14.53M
2023Q4
2795
262.30M
92.80%
-573.37K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
25.62M
9.59%
+27.96K
+0.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
12.64M
4.73%
+229.62K
+1.85%
Sep 30, 2025
State Street Investment Management (US)
12.12M
4.54%
-145.49K
-1.19%
Sep 30, 2025
MFS Investment Management
10.55M
3.95%
-863.89K
-7.57%
Sep 30, 2025
Dodge & Cox
9.31M
3.48%
+354.62K
+3.96%
Sep 30, 2025
Fidelity Management & Research Company LLC
8.27M
3.1%
-538.79K
-6.12%
Sep 30, 2025
Sanders Capital, LLC
7.83M
2.93%
+35.15K
+0.45%
Sep 30, 2025
GQG Partners, LLC
6.79M
2.54%
+1.02M
+17.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.00M
2.25%
+39.79K
+0.67%
Sep 30, 2025
T. Rowe Price Associates, Inc.
10.90M
4.08%
+1.00M
+10.12%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
7.92%
VictoryShares Free Cash Flow ETF
3.31%
Invesco Dynamic Buyback Achievers ETF
3.22%
Monarch Dividend Plus Index ETF
2.79%
TrueShares Low Volatility Equity Income ETF
2.58%
Hennessy Sustainable ETF
2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
2.16%
Brandes US Value ETF
1.9%
Bushido Capital US Equity ETF
1.89%
Davis Select US Equity ETF
1.86%
View more
iShares U.S. Healthcare Providers ETF
Proportion7.92%
VictoryShares Free Cash Flow ETF
Proportion3.31%
Invesco Dynamic Buyback Achievers ETF
Proportion3.22%
Monarch Dividend Plus Index ETF
Proportion2.79%
TrueShares Low Volatility Equity Income ETF
Proportion2.58%
Hennessy Sustainable ETF
Proportion2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
Proportion2.16%
Brandes US Value ETF
Proportion1.9%
Bushido Capital US Equity ETF
Proportion1.89%
Davis Select US Equity ETF
Proportion1.86%
Dividend
A total of
5.74B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 05, 2026
CI.NB Final Cash Dividend of gross USD 1.56 paid on Mar 19, 2026 going ex on Mar 05, 2026 with reinvestment option
Mar 05, 2026
Mar 19, 2026
Mar 05, 2026
Oct 22, 2025
CI.NB Final Cash Dividend of gross USD 1.51 paid on Dec 18, 2025 going ex on Dec 04, 2025 with reinvestment option
Dec 04, 2025
Dec 18, 2025
Dec 04, 2025
Jul 22, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Sep 18, 2025 going ex on Sep 04, 2025 with reinvestment option
Sep 04, 2025
Sep 18, 2025
Sep 04, 2025
Apr 23, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Jun 18, 2025 going ex on Jun 03, 2025 with reinvestment option
Jun 03, 2025
Jun 18, 2025
Jun 03, 2025
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024 with reinvestment option
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
View more
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
